| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1553084A1 Piperidine derivative, process for producing the same, and use |
| 07/13/2005 | EP1551834A1 Substituted quinazolinone compounds |
| 07/13/2005 | EP1551829A2 Novel compounds with antibacterial activity |
| 07/13/2005 | EP1551827A1 Piperidine derivatives as ccr5 inhibitors |
| 07/13/2005 | EP1551818A1 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands |
| 07/13/2005 | EP1551815A1 Thiazole compounds for the treatment of neurodegenerative disorders |
| 07/13/2005 | EP1551813A2 Chemical compounds |
| 07/13/2005 | EP1551812A2 Mitotic kinesin inhibitors |
| 07/13/2005 | EP1551811A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 07/13/2005 | EP1551810A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 07/13/2005 | EP1551804A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/13/2005 | EP1551803A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/13/2005 | EP1551425A2 Therapeutic formulations |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1161415B1 N-cyanomethylamides as protease inhibitors |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639158A Thiazole derivatives as NPY receptor antagonists |
| 07/13/2005 | CN1639157A 2-acylaminothiazole derivative or salt thereof |
| 07/13/2005 | CN1639154A Pyranones useful as ATM inhibitors |
| 07/13/2005 | CN1639149A Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 07/13/2005 | CN1639146A Fused tricyclic heterocycles useful for treating hyper-proliferative disorders |
| 07/13/2005 | CN1639145A Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/13/2005 | CN1639141A New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/13/2005 | CN1639139A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
| 07/13/2005 | CN1639138A Biphenylmethyl-thiazolidinediones and analogues and their use as PPAR-gamma activators |
| 07/13/2005 | CN1639135A N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials |
| 07/13/2005 | CN1639133A Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides |
| 07/13/2005 | CN1639123A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 07/13/2005 | CN1638776A Substituted 3-aryl-5-aryl-[1, 2, 4]-oxadiazoles and analogs |
| 07/13/2005 | CN1638768A Thiazole and oxazole derivatives that modulate PPAR activity |
| 07/13/2005 | CN1638761A Azetidine derivatives as CCR-3 receptor antagonists |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1637624A Organophotoreceptor with charge transport material having a thiiranyl group |
| 07/13/2005 | CN1637018A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby |
| 07/13/2005 | CN1636992A Process for producing quinazoline ditosylate salt compounds |
| 07/13/2005 | CN1636986A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636985A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636984A Benzophenones as inhibitors of reverse transcriptase |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636981A Uracil compounds and their use |
| 07/13/2005 | CN1636977A 1, 3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 07/13/2005 | CN1636593A Novel effectors of dipeptidyl peptidase IV |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210268C (Cyclo) alkyl substituted-gamma-aminobutyric acid derivatives (=GABA analogurs), their preparation and their use in the treatment of neurolog disorders |
| 07/13/2005 | CN1210267C 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 07/13/2005 | CN1210265C Phthalazine derivatives and remedies for erectile dysfunction |
| 07/12/2005 | US6916957 Antiinflammatory agents; antihistamines; antiallergens |
| 07/12/2005 | US6916930 Radioactive iodine-labeled compound |
| 07/12/2005 | US6916841 Inhibitors of phospholipase enzymes |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 07/12/2005 | US6916819 Benzimidazole and pyridylimidazole derivatives |
| 07/12/2005 | US6916813 (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916806 Such as 2-(2-isopropylphenyl)imino-5,5-dimethyl-1,3-thiazine which has binding activity to the cannabinoid type-2 receptors |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916803 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| 07/12/2005 | CA2105867C Novel imidazole derivatives, their preparation and therapeutic applications |
| 07/07/2005 | WO2005061493A2 Polymorphic form b2 of ziprasidone base |
| 07/07/2005 | WO2005061492A1 Nitrogen-containing heterocyclic compounds and drugs comprising the same as the active ingredient |
| 07/07/2005 | WO2005061489A1 Heterocyclic derivatives as gpcr receptor agonists |
| 07/07/2005 | WO2005061487A1 Hiv protease inhibiting compounds |
| 07/07/2005 | WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005061470A1 1-akan-2-ol substituted piperazine and piperidine compounds |
| 07/07/2005 | WO2005061466A1 Novel phenylalanine derivative |
| 07/07/2005 | WO2005061450A2 Hiv protease inhibiting sulfonamides |
| 07/07/2005 | WO2005060970A1 Pyrimidines with tie2 (tek) activity |
| 07/07/2005 | WO2005060969A1 Pyrimidines with tie2 (tek) activity |
| 07/07/2005 | WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | WO2005060959A1 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 07/07/2005 | WO2005060958A1 (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes |
| 07/07/2005 | WO2005060665A2 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 07/07/2005 | WO2005060571A2 Antiprotozoal imidazopyridine compounds |
| 07/07/2005 | WO2005049593A3 N-acylsulfonamide apoptosis promoters |
| 07/07/2005 | WO2005042521A3 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 07/07/2005 | WO2005042498A3 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 07/07/2005 | WO2005040160A3 Processes for preparation of ziprasidone |
| 07/07/2005 | WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 07/07/2005 | WO2005037779A3 Novel dipeptidyl peptidase iv inhibitors used for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 07/07/2005 | US20050148770 Synthetic methodology for the reductive alkylation at the C-3 position of indoles |
| 07/07/2005 | US20050148662 compounds possess the ability to recognize and promote oxidation and allow for scission of a nucleic acid at specific positions and splitting (if exposed to piperidine) |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148640 For therapy and prophylaxis of heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases, immunologically-mediated diseases |
| 07/07/2005 | US20050148631 Modulation of steroid enzymes in mammals as antidiabetic agents, for treatment of obesity, vision defects, lowering fats in blood, for treatment of osteoporosis, tuberculosis or atherosclerosis in mammals |
| 07/07/2005 | US20050148627 Benzopyran compounds for use in the treatment and prevention of inflammation related conditions |
| 07/07/2005 | US20050148623 HIV protease inhibiting compounds |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050148601 Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148586 Quinoxalinones |
| 07/07/2005 | US20050148581 Quinolines; 1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol; Mycobacterium tuberculosis, M. bovis, M. avium and M. marinum; reduces the total length of treatment and the frequency of drug administration; multi-drug and antibiotic resistance |
| 07/07/2005 | US20050148580 Non-opioid analgesics for chronic and acute pain; 1-[1-(p-phenylbenzyl)-4-piperidinyl]-2,1,3-benzothiadiazol-2,2-dione; modulation of the opioid and ORL I receptors; agonist or antagonist activity at the CNS mu, delta and kappa receptors greater than morphine |
| 07/07/2005 | US20050148572 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs |
| 07/07/2005 | US20050148548 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/07/2005 | US20050147904 Organophotoreceptor with charge transport material having a thiiranyl group |